Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation

Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin–nicotinamide-induced experimental diabetic rats

(2012) T. Annadurai et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet

(2011) Peng Pu et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis

(2011) Meng Lee et al.   ATHEROSCLEROSIS

Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort

(2011) Raul Zamora-Ros et al.   BRITISH JOURNAL OF NUTRITION

Up-regulation of PPARγ, heat shock protein-27 and -72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes

(2011) Ashok Kumar Sharma et al.   BRITISH JOURNAL OF NUTRITION

Antiatherogenic properties of flavonoids: Implications for cardiovascular health

(2011) Erin E. Mulvihill et al.   CANADIAN JOURNAL OF CARDIOLOGY

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

(2011) E. E. Mulvihill et al.   DIABETES

Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice

(2011) Audrey Chanet et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Citrus flavonoid 5-demethylnobiletin suppresses scavenger receptor expression in THP-1 cells and alters lipid homeostasis in HepG2 liver cells

(2011) Jui-Hung Yen et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Naringenin Decreases Progression of Atherosclerosis by Improving Dyslipidemia in High-Fat–Fed Low-Density Lipoprotein Receptor–Null Mice

(2010) Erin E. Mulvihill et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Creating and curing fatty hearts

(2010) Raffay S Khan et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

PPARs as therapeutic targets in cardiovascular disease

(2010) Marc van Bilsen et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation

(2010) Josep M. Orellana-Gavaldà et al.   HEPATOLOGY

The Citrus Flavonoids Hesperidin and Naringin Do Not Affect Serum Cholesterol in Moderately Hypercholesterolemic Men and Women

(2010) Isabelle Demonty et al.   JOURNAL OF NUTRITION

Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARα, PPARγ and LXRα

(2010) Jonathan Goldwasser et al.   PLoS One

Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity

(2010) Roger H. Unger et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The many ways to regulate glucose transporter 4This paper is one of a selection of papers published in this Special Issue, entitled 14th International Biochemistry of Exercise Conference – Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s usual peer review process.

(2009) Amira Klip   Applied Physiology Nutrition and Metabolism

Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion

(2009) Kazuhiro Kunimasa et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors

(2009) D. S. Lee et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator-Activated Receptor-  Coactivator-1  Expression

(2009) J. L. Estall et al.   DIABETES

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor-Null Mice With Diet-Induced Insulin Resistance

(2009) E. E. Mulvihill et al.   DIABETES

Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet

(2009) M. Schreurs et al.   DIABETES OBESITY & METABOLISM

Regulatory enzymes of mitochondrial β-oxidation as targets for treatment of the metabolic syndrome

(2009) M. Schreurs et al.   Obesity Reviews

Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance

(2008) Timothy R. Koves et al.   Cell Metabolism

Fatty liver, insulin resistance, and dyslipidemia

(2008) Martin Adiels et al.   Current Diabetes Reports

Insulin sensitivity: modulation by nutrients and inflammation

(2008) Simon Schenk et al.   JOURNAL OF CLINICAL INVESTIGATION

Thematic Review Series: Glycerolipids.DGAT enzymes and triacylglycerol biosynthesis

(2008) Chi-Liang Eric Yen et al.   JOURNAL OF LIPID RESEARCH

Nuclear receptors, mitochondria and lipid metabolism

(2008) William A. Alaynick   MITOCHONDRION

Naringenin and hesperetin, two flavonoids derived fromCitrus aurantiumup-regulate transcription of adiponectin

(2008) Li Liu et al.   PHYTOTHERAPY RESEARCH